They, too, concluded that LSD1’s enzymatic action was not advantageous to the AML cells, but, it was rather the interaction of LSD1 with the transcriptional repressors GFI1 and GFI1b that promoted the disease [87,88]. This evidence concerns the gene KDM1A and acute myeloid leukemia.